MPOX (MONKEYPOX)
Clinical trials for MPOX (MONKEYPOX) explained in plain language.
Never miss a new study
Get alerted when new MPOX (MONKEYPOX) trials appear
Sign up with your email to follow new studies for MPOX (MONKEYPOX), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox vaccine trial for infants: could a Half-Dose protect just as well?
⭐️ VACCINE ⭐️ OngoingThis Phase 3 study is testing the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo, a region heavily affected by mpox. Researchers are comparing a standard dose to a half-dose to see if the lower dose is still effective a…
Matched conditions: MPOX (MONKEYPOX)
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:25 UTC
-
Mpox vaccine trial targets HIV-Positive adults in DRC
Prevention OngoingThis study is testing whether the MVA-BN mpox vaccine is safe and triggers a strong immune response in 600 adults living with HIV in Kinshasa, DRC. Participants receive two vaccine doses 28 days apart and are grouped by their CD4 count. The goal is to see if the vaccine works wel…
Matched conditions: MPOX (MONKEYPOX)
Phase: PHASE2 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
AI toolkit aims to speed up epidemic response for diseases like COVID-19 and mpox
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new AI-powered toolkit designed to help public health officials at local CDC offices respond more quickly to emerging infectious diseases such as COVID-19, mpox, influenza, and dengue. The toolkit combines data analysis, risk assessment, decision support, and e…
Matched conditions: MPOX (MONKEYPOX)
Phase: NA • Sponsor: Peking University • Aim: Knowledge-focused
Last updated Jul 02, 2026 03:00 UTC